CollaGenex is developing dermatological applications of its proprietary IMPACS technology. Oracea (doxyxcycline, USP) 40 mg* was approved by the FDA on May 26, 2006. More
West Pharmaceutical Services supports global pharmaceutical and healthcare markets with products and services that enhance the effectiveness of drug delivery and product dispensing. More
Using its unique technology, biopharmaceutical company, Aptagen develops targeted drugs and licenses out new drugs to global pharmaceutical companies. More